BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 17655519)

  • 1. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Lunde JL; Nelson RE; Storandt HF
    Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
    Gu J; Huang Y
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-onset neutropenia with divalproex sodium.
    Stoner SC; Deal E; Lurk JT
    Ann Pharmacother; 2008 Oct; 42(10):1507-10. PubMed ID: 18698009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ertapenem-associated seizures in a peritoneal dialysis patient.
    Seto AH; Song JC; Guest SS
    Ann Pharmacother; 2005 Feb; 39(2):352-6. PubMed ID: 15644469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probable valproate sodium-associated hypotension.
    Ota KS
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in serum valproic acid levels during treatment with ertapenem.
    Liao FF; Huang YB; Chen CY
    Am J Health Syst Pharm; 2010 Aug; 67(15):1260-4. PubMed ID: 20651316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First case report of suspected onset of convulsive seizures due to co-administration of valproic acid and tebipenem.
    Shihyakugari A; Miki A; Nakamoto N; Satoh H; Sawada Y
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):92-6. PubMed ID: 25407257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of carbapenem antibiotics on plasma concentrations of valproic acid.
    Mancl EE; Gidal BE
    Ann Pharmacother; 2009 Dec; 43(12):2082-7. PubMed ID: 19934386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
    de Maat MM; van Leeuwen HJ; Edelbroek PM
    Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER?
    Reed RC; Dutta S
    Ther Drug Monit; 2006 Jun; 28(3):413-8. PubMed ID: 16778728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases.
    Park MK; Lim KS; Kim TE; Han HK; Yi SJ; Shin KH; Cho JY; Shin SG; Jang IJ; Yu KS
    Ther Drug Monit; 2012 Oct; 34(5):599-603. PubMed ID: 22929406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.
    Miller AD; Ball AM; Bookstaver PB; Dornblaser EK; Bennett CL
    Pharmacotherapy; 2011 Apr; 31(4):408-23. PubMed ID: 21449629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.
    Myers AP; Watson TA; Strock SB
    Pharmacotherapy; 2015 Mar; 35(3):e9-e12. PubMed ID: 25756365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somnambulism due to probable interaction of valproic acid and zolpidem.
    Sattar SP; Ramaswamy S; Bhatia SC; Petty F
    Ann Pharmacother; 2003 Oct; 37(10):1429-33. PubMed ID: 14519043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
    Muzyk AJ; Candeloro CL; Christopher EJ
    Gen Hosp Psychiatry; 2010; 32(5):560.e1-3. PubMed ID: 20851283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
    Plakogiannis R; Nogid A
    Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.